Type : Pre-Bid Notification
Non-Clinical Studies and Laboratory Support
Non-Clinical Studies and Laboratory Support
N01DA-21-8957 for “In Vitro Metabolism and Non-Clinical ADME Studies".This Request for Proposal is prepared in accordance with the Uniform Contract Format prescribed for Government Wide application by the Federal Acquisition Regulation (FAR). The Uniform Contract Format is both a Request for Proposal and a contract award document.
This is a combined synopsis/solicitation for commercial items prepared in accordance with (IAW) the format in FAR Subpart 12.6, as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; proposals are being requested and a written solicitation will not be issued. This is a request for proposal (RFP) for commercial items IAW the procedures of FAR Part 12 – Acquisition of Commercial Items, in conjunction with FAR Part 15 – Contracting by Negotiation. This acquisition is issued as a Request for Proposal (RFP).This solicitation document incorporates provisions and clauses in effect through Federal Acquisition Circular FAC 2023-01, effective December 30, 2022. All questions regarding...
NON-CLINICAL AND LABORATORY SUPPORT Solicitation ID/Procurement Identifier: 75F40123R00157 Ultimate Completion Date: Fri Sep 29 17:00:00 GMT 2028
See revised attached documents.Amendment 1 - Correction to ordering period of performances and extented proposal response date.
Added: Apr 13, 2017 4:45 pm The South Dakota Army national Guard (SDARNG) has a requirement for Non-Clinical Case Manager and Non-Clinical Care Coordinators to support the SD Medical Command.
This solicitation has been amended to provide responses to clarification questions.The Food and Drug Administration (FDA), Center for Drug Evaluation and Research (CDER) performs an essential public health task by making sure that safe and effective drugs are available to improve the health of people in the United States. The services required under this effort may include target-based assays, safety pharmacology, ADME (absorption, distribution, metabolism, excretion), drug interaction assays/assessment, translational biology including biomarker evaluation, biotherapeutics characterization, or analyzing drug concentration in biological matrices on a task-by-task basis. Note: This requirement was previously solicited under FDA-RFP-75F40122R0...